HAEMONETICS CORP (HAE) › Shareholders' EquityHAEMONETICS CORP (HAE) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $494.19M2009: $539.88M2010: $593.12M2011: $686.14M2012: $732.63M2013: $769.18M2014: $837.89M2015: $826.12M2016: $721.57M2017: $739.61M2018: $752.43M2019: $667.87M2020: $587.11M2021: $731.67M2022: $749.42M2023: $818.00M2024: $959.96M2025: $820.84M2026: $796.32M$796.32M2008Shareholders' Equity (USD)2026Fiscal YearShareholders' EquityChange YoY2026$796.32M-3.0%2025$820.84M-14.5%2024$959.96M+17.4%2023$818.00M+9.2%2022$749.42M+2.4%2021$731.67M+24.6%2020$587.11M-12.1%2019$667.87M-11.2%2018$752.43M+1.7%2017$739.61M+2.5%2016$721.57M-12.7%2015$826.12M-1.4%2014$837.89M+8.9%2013$769.18M+5.0%2012$732.63M+6.8%2011$686.14M+15.7%2010$593.12M+9.9%2009$539.88M+9.2%2008$494.19M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share